You are here: Industry Insights > CHMP

News List

Sanofi and Regeneron receive CHMP positive opinion for rheumatoid arthritis treatment europeanpharmaceuticalreview
May 02, 2017
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the marketing authorisation of Sanofi and Regeneron Pharmaceuticals’ Kevzara (sarilumab).
BioMarin’s Brineura receives positive opinion from CHMP to treat CLN2 disease pharmaceutical-technology
April 25, 2017
BioMarin Pharmaceutical has announced that European Medicines Agency’s (EMA) Committee for Medicinal Products...
CHMP backs 11 medicines for European approval pharmatimes
April 25, 2017
Eleven new medicines have taken a giant leap towards approval in Europe after winning backing from the European ...
AbbVie receives CHMP positive opinion for Hep C tablet combination europeanpharmaceuticalreview
March 03, 2017
The European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion for Abbvie’s shorter, eight-week treatment of Viekirax...
Janssen’s monoclonal antibody receives positive CHMP opinion to treat multiple myeloma europeanpharmaceuticalreview
March 01, 2017
The Committee for Medicinal products for human use (CHMP) of the European Medicines Agency (EMA) has recommended broadening the existing marketing authorisation for Janssen‘s Darzalex (daratumumab).
AbbVie Receives CHMP Positive Opinion for Eight-Week Treatment Option with VIEKIRAX® + EXVIERA® February 28, 2017
AbbVie announced that the European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion for a shorter,
DARZALEX® Receives Positive CHMP Opinion for the Treatment of Multiple Myeloma americanpharmaceuticalreview
February 27, 2017
Janssen-Cilag International NV announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended broadening the existing marketing authorization for DARZALEX®▼ (daratumumab).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page